Renal Medical Devices and Services Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product (Dialysis Equipment, Renal Denervation Devices, Wearable Artificial Kidney Device, and Distal Embolic Protection Devices), Application (Kidney Failure, Chronic Kidney Disease, End-stage Kidney Disease, Renal Kidney Stone Disease, Hypertension, Diabetes, and Others), B
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationRenal Medical Devices and Services Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product (Dialysis Equipment, Renal Denervation Devices, Wearable Artificial Kidney Device, and Distal Embolic Protection Devices), Application (Kidney Failure, Chronic Kidney Disease, End-stage Kidney Disease, Renal Kidney Stone Disease, Hypertension, Diabetes, and Others), B
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 14.28 Billion |
| CAGR (2024-2028) | 5.20% |
| Fastest Growing Segment | Chronic Kidney Disease Segment |
| Largest Market | North America |
Market Overview
Global Renal Medical Devices and Services Market has valued at USD 14.28 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 5.20% and will probably reach billion by 2028. Renal medical devices are specialized medical instruments, equipment, and devices designed to diagnose, treat, or manage conditions related to the kidneys and the urinary system. These devices play a critical role in the field of nephrology (the study of kidneys) and are used in various clinical settings, including hospitals, clinics, and home care. Renal medical devices encompass a wide range of technologies and tools aimed at addressing kidney-related issues. Various imaging devices, such as ultrasound machines, CT scanners, and MRI machines, are used to visualize the kidneys and diagnose kidney-related conditions, including tumors, cysts, and kidney stones. The increasing incidence of kidney diseases, including chronic kidney disease (CKD) and end-stage renal disease (ESRD), is a significant driver. Factors such as aging populations, diabetes, hypertension, and lifestyle-related health issues contribute to a growing patient pool in need of renal medical devices and services.
The global demographic shift toward an aging population has led to a higher prevalence of kidney-related issues. Older individuals are more susceptible to kidney disease, and this demographic trend is expected to continue driving demand for renal medical devices and services. Continuous innovation in renal medical devices, such as dialysis machines, monitoring equipment, and surgical instruments, drives market growth. Advancements improve treatment outcomes, patient comfort, and the efficiency of care delivery. Rising awareness among patients and healthcare providers about kidney diseases and the importance of early diagnosis and treatment encourages greater utilization of renal medical devices and services. Government initiatives aimed at improving healthcare infrastructure and access to renal care services can be a significant driver. Public health programs and insurance coverage often support the use of renal medical devices and services.
Key Market Drivers
Advancements in Technology
Dialysis machines have seen significant improvements in terms of efficiency, accuracy, and patient comfort. These advancements include better fluid management, reduced treatment times, and enhanced safety features. The development of wearable and portable dialysis devices has allowed patients greater flexibility in their treatment options. These devices are more compact and can be used at home or while traveling. Hemodiafiltration (HDF) is an advanced form of hemodialysis that combines hemodialysis and hemofiltration. It offers better removal of toxins and improved patient outcomes. HDF machines have become more widely found at. Researchers are working on the development of artificial kidneys that can mimic the functions of natural kidneys. These devices have the potential to revolutionize renal care by providing a more efficient and portable solution. Telehealth platforms and remote monitoring technologies allow healthcare providers to monitor patients' vital signs and treatment progress remotely. This has become especially important during the COVID-19 pandemic and can improve access to care.
Implantable devices, such as artificial kidney prototypes and bioartificial kidneys, are being researched and developed. These devices have the potential to provide continuous renal replacement therapy without the need for external equipment. Many renal medical devices are becoming smaller and more portable, enabling patients to carry out treatments without being confined to a clinical setting. 3D printing technology is being used to create customized solutions, including prosthetic kidneys and models for surgical planning, which can improve the precision of procedures. AI and machine learning algorithms are being used to analyze patient data, predict disease progression, and optimize treatment plans. These technologies can enhance diagnostic accuracy and treatment effectiveness. Advances in biocompatible materials are improving the safety and longevity of implantable renal devices. These materials reduce the risk of adverse reactions and complications. Regenerative medicine approaches, such as tissue engineering, are being explored for kidney regeneration and repair. These techniques hold promise for repairing damaged kidneys. Nanotechnology is being applied to the development of nanoscale medical devices and drug delivery systems that can target kidney-related issues more precisely. Many renal devices now offer remote access and connectivity features, allowing healthcare providers to adjust settings and monitor patients remotely, improving the quality of care and patient convenience. Point-of-care testing devices for kidney function are becoming more advanced and accessible, enabling quicker and more convenient assessments. This factor will help in the development of Global Renal Medical Devices and Services Market.
Growing Aging Population
The aging population is associated with an increased prevalence of kidney-related conditions, such as chronic kidney disease (CKD) and end-stage renal disease (ESRD). Older individuals are more susceptible to kidney diseases due to the natural aging process and the accumulation of health issues over time. This demographic group experiences a higher incidence of CKD and ESRD, leading to increased demand for renal medical devices and services. Advances in healthcare and medical treatments have extended the lifespan of the elderly population. As people live longer, the likelihood of developing kidney-related conditions also increases, resulting in a continued need for renal care. Elderly patients with kidney disease often require specialized and ongoing care. They may need dialysis, medications, monitoring, and surgical interventions, all of which contribute to the demand for renal medical devices and services. Older individuals frequently have comorbidities such as diabetes and hypertension, which are major risk factors for kidney diseases. The presence of multiple chronic conditions necessitates comprehensive renal care, further driving the market.
Many elderly patients prefer home-based dialysis due to the convenience and reduced exposure to healthcare facilities. This preference has led to a growing demand for home dialysis equipment and services. Nephrology as a medical specialty has seen a greater emphasis on geriatric nephrology, addressing the unique needs and challenges of elderly patients with kidney diseases. This specialization drives research and innovation in renal care for older adults. Healthcare policies and programs often prioritize care for the aging population, including those with kidney diseases. Government support and insurance coverage contribute to the accessibility of renal medical devices and services. Companies in the renal medical devices and services sector recognize the growth potential in serving the aging population and are investing in developing products and services tailored to the unique needs of older patients. The aging population's complex healthcare needs have spurred research and innovation in renal care, leading to the development of advanced technologies and treatments. Healthcare providers, medical device manufacturers, and pharmaceutical companies collaborate with geriatric specialists to create integrated solutions for kidney disease management in older adults. This factor will pace up the demand of Global Renal Medical Devices and Services Market.
Rising Demand of Minimally Invasive Procedures
Minimally invasive procedures have indeed contributed to the demand for Global Renal Medical Devices and Services. These procedures offer several advantages over traditional open surgeries in the field of renal care, leading to increased adoption and driving the demand for related medical devices and services. Minimally invasive procedures typically involve smaller incisions or access points, resulting in less tissue trauma and reduced pain for patients. This often leads to faster post-operative recovery, shorter hospital stays, and decreased healthcare costs. Minimally invasive techniques can reduce the risk of surgical complications, including infection and bleeding, compared to open surgeries. This increased safety profile is attractive to both patients and healthcare providers. Patients generally prefer minimally invasive procedures due to less discomfort, smaller scars, and quicker return to normal activities. A positive patient experience can lead to greater patient compliance with follow-up care and improved outcomes. Advances in minimally invasive techniques have expanded the range of conditions that can be treated using these methods. This includes the removal of kidney stones, tumor ablation, and certain kidney surgeries.
Minimally invasive procedures often utilize advanced imaging technologies, such as laparoscopy and robotic-assisted surgery, to provide surgeons with enhanced visualization and precision during surgery. Many minimally invasive renal procedures are performed on an outpatient basis or require shorter hospital stays, which can lead to cost savings for healthcare facilities and insurers. Smaller incisions and access points result in minimal scarring, which can be particularly important for patients concerned about cosmetic outcomes. Minimally invasive techniques often involve less blood loss compared to open surgeries, reducing the need for blood transfusions and post-operative complications. The use of robotic-assisted surgery in renal procedures has increased. These systems offer surgeons greater precision and dexterity, enabling complex procedures to be performed with minimally invasive approaches. Patients typically experience shorter recovery times after minimally invasive renal procedures, allowing them to return to their daily activities more quickly. While minimally invasive procedures may have higher upfront equipment costs, they can be cost-effective in the long run due to reduced hospitalization and post-operative care expenses. Many minimally invasive renal procedures can be performed in outpatient clinics or ambulatory surgery centers, further increasing patient convenience, and reducing the burden on hospitals. This factor will accelerate the demand of Global Renal Medical Devices and Services Market.
Key Market Challenges
Economic Uncertainty
Economic instability and uncertainty can affect various aspects of the market, including purchasing decisions, healthcare budgets, and investment in medical devices and services. During periods of economic uncertainty, healthcare facilities, including hospitals and clinics, may face budget constraints. This can lead to limitations on capital expenditures, including the acquisition of new renal medical devices or the expansion of renal care services. Economic uncertainty can make healthcare organizations cautious about making major investments. They may delay the purchase of new renal medical equipment or upgrades to existing devices, which can affect market demand. Economic challenges can result in pricing pressure for medical device manufacturers and service providers. Healthcare facilities may seek cost-effective solutions and negotiate for lower prices, affecting profit margins in the industry. Economic uncertainty may lead to reduced funding for research and development initiatives aimed at developing new renal medical devices and services. This can slow down innovation in the field. Medical device companies may face challenges in securing financing for product development and expansion during periods of economic instability. This can hinder their ability to bring new products to the market. Economic uncertainty can contribute to market volatility, affecting the stock prices of medical device manufacturers and potentially reducing investor confidence in the sector. Economic uncertainty can influence patient behavior. Patients may postpone elective procedures or seek lower-cost alternatives for renal care, affecting the utilization of medical devices and services.
Environmental Sustainability
Dialysis and renal care generate a significant amount of medical waste, including used dialysis supplies, packaging materials, and disposable medical devices. Proper disposal and management of this waste to minimize environmental harm is a challenge. Dialysis machines and healthcare facilities in general consume a substantial amount of energy. Energy-efficient equipment and sustainable facility design are becoming important considerations to reduce the environmental footprint. Dialysis requires a substantial amount of water for the purification process. Efficient water usage and wastewater management are important for minimizing environmental impact, especially in regions with water scarcity. Many renal medical devices and supplies are designed for single use to maintain sterility and reduce infection risk. However, this contributes to increased waste generation. Finding sustainable alternatives or recycling solutions for these products can be challenging. The use of chemical disinfectants in dialysis and renal care can have environmental implications. Proper disposal of these chemicals and the development of eco-friendly alternatives are important considerations. The production and distribution of renal medical devices and supplies can have a significant environmental impact. Companies are increasingly evaluating their supply chain practices reducing carbon emissions and minimizing environmental harm. Increasing the lifespan of medical devices and equipment can reduce waste generation. However, balancing product durability with the need for up-to-date technology and safety standards is a challenge.
Key Market Trends
Home Hemodialysis
Home hemodialysis refers to the provision of hemodialysis treatment for patients with end-stage renal disease (ESRD) in the comfort of their own homes. Many patients prefer home hemodialysis over in-center treatment because it offers greater flexibility and the ability to tailor treatment schedules to their daily lives. This preference for a more patient-centered approach has driven the demand for home hemodialysis devices and services. Home hemodialysis allows patients to have more control over their treatment, which can lead to an improved quality of life. Patients can dialyze more frequently or for longer durations, which may result in better clinical outcomes. Patients undergoing in-center hemodialysis often need to travel to a healthcare facility multiple times a week. Home hemodialysis eliminates the need for such frequent travel, reducing the burden on patients and their families. Home hemodialysis can reduce a patient's exposure to infections and diseases commonly found in healthcare facilities, which is particularly important during the COVID-19 pandemic and for patients with compromised immune systems. Home hemodialysis can be cost-effective for both patients and healthcare systems. It reduces the cost of facility-based care, including overhead expenses associated with dialysis centers. Medical device manufacturers have developed more user-friendly and compact home hemodialysis machines. These devices are designed to be easy to use and maintain, making home treatment more accessible to a broader range of patients. Telehealth and remote monitoring technologies enable healthcare providers to monitor patients' progress and adjust treatment remotely, enhancing the safety and effectiveness of home hemodialysis.
Segmental Insights
Product Insights
In 2022, the Global Renal Medical Devices and Services Market largest share was held by Dialysis Equipment segment and is predicted to continue expanding over the coming years.
Application Insights
In 2022, the Global Renal Medical Devices and Services Market largest share was held by chronic kidney disease segment in the forecast period and is predicted to continue expanding over the coming years.
Regional Insights
The North America region has the largest share in the Global Renal Medical Devices and Services Market in 2022.
Recent Developments
- In October 2021, The Paradise ultrasonic renaldenervation system from ReCor Medical, Inc., a fully owned subsidiary of OtsukaMedical Devices Co., Ltd., has launched in Europe. Germany now offers theParadise system for the treatment of uncontrolled hypertension. Heart Centre Leipzigin Leipzig, Germany, and Saarland University Hospital in Homburg/Saar, Germany,are the first facilities to offer the surgery commercially. The RADIANCE-HTNSOLO and TRIO trials of the Paradise system were studied by Professor FelixMahfoud, MD, of Saarland University Hospital. Additionally, he is the directorof the German Society of Cardiology's Arterial Hypertension Working Group.
- In May 2022, to improve patient treatmentexperiences and general results, Medtronic pl and DaVita Inc. announced theirintention to establish a new, independent medical device company("NewCo" or "the Company") with a focus on renal care. NewCowill be ideally positioned to promote the development of innovative medicinesfor patients with kidney failure by combining Medtronic's skills as ahealthcare technology leader and DaVita's significant expertise as acomprehensive renal care provider. The Company will concentrate on creating abroad range of innovative kidney care products and solutions, includingupcoming home-based devices, to increase patient access to various dialysistreatments.
- In April 2023, the founding of Mozarc Medical, anindependent new company dedicated to changing kidney health and advancingpatient-centered technology solutions, was announced by Medtronic plc andDaVita Inc. Health care company DaVita is committed to modernising care deliveryto raise patient quality of life across the globe. The business is a leader inclinical quality and innovation and one of the largest renal care serviceproviders in the United States. DaVita provides care for patients at everystage and location of their path towards better kidney health, from halting theprogression of kidney disease to supporting transplantation, from emergencyhospital treatment to home dialysis.
Key Market Players
- Abbott Laboratories
- B Braun Melsungen AG
- Baxter International Inc
- Becton, Dickinson, andCompany
- Boston ScientificCorporation
- DaVita Healthcare Partners,Inc
- Fresenius SE & Co. KGaA
- Infomed SA
- Medtronic Inc.
- Nipro Corporation
| By Technology | By End User | By Region |
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy